MX2010010016A - Preparacion de composicion farmaceutica para aumentar densidad mineral osea. - Google Patents
Preparacion de composicion farmaceutica para aumentar densidad mineral osea.Info
- Publication number
- MX2010010016A MX2010010016A MX2010010016A MX2010010016A MX2010010016A MX 2010010016 A MX2010010016 A MX 2010010016A MX 2010010016 A MX2010010016 A MX 2010010016A MX 2010010016 A MX2010010016 A MX 2010010016A MX 2010010016 A MX2010010016 A MX 2010010016A
- Authority
- MX
- Mexico
- Prior art keywords
- cart
- preparation
- pharmaceutical composition
- derived peptide
- bone mineral
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title abstract 2
- 229910052500 inorganic mineral Inorganic materials 0.000 title abstract 2
- 239000011707 mineral Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102100035932 Cocaine- and amphetamine-regulated transcript protein Human genes 0.000 abstract 5
- 101000715592 Homo sapiens Cocaine- and amphetamine-regulated transcript protein Proteins 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 210000002966 serum Anatomy 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere al uso de una cocaína y un péptido derivado de la transcripción regulada por anfetamina (CART) para la preparación de una composición farmacéutica para el aumento de la densidad mineral ósea proporcionando continuamente niveles elevados en suero del péptido derivado de CART en un sujeto que será tratado. Convenientemente, los niveles elevados en suero del péptido derivado de CART se proporcionan continuamente a través de la liberación lenta del péptido derivado de CART durante un periodo de tiempo prolongado de una formulación dé liberación lenta.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08005279 | 2008-03-20 | ||
| PCT/EP2009/053149 WO2009115525A2 (en) | 2008-03-20 | 2009-03-17 | Preparation of a pharmaceutical composition for increasing bone mineral density |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010010016A true MX2010010016A (es) | 2010-09-30 |
Family
ID=39744830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010010016A MX2010010016A (es) | 2008-03-20 | 2009-03-17 | Preparacion de composicion farmaceutica para aumentar densidad mineral osea. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20100075893A1 (es) |
| EP (1) | EP2265280A2 (es) |
| JP (1) | JP2011515363A (es) |
| KR (1) | KR20100135751A (es) |
| CN (1) | CN101977624A (es) |
| AR (1) | AR071010A1 (es) |
| AU (1) | AU2009226966A1 (es) |
| BR (1) | BRPI0908423A2 (es) |
| CA (1) | CA2717459A1 (es) |
| CL (1) | CL2009000675A1 (es) |
| CO (1) | CO6290697A2 (es) |
| IL (1) | IL207542A0 (es) |
| MX (1) | MX2010010016A (es) |
| PE (1) | PE20091690A1 (es) |
| RU (1) | RU2010142903A (es) |
| TW (1) | TW201000117A (es) |
| WO (1) | WO2009115525A2 (es) |
| ZA (1) | ZA201006004B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103030689B (zh) * | 2012-12-27 | 2014-09-24 | 无锡米度生物技术有限公司 | 一种cart多肽化合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522403D0 (en) * | 1995-11-01 | 1996-01-03 | Hoechst Roussel Ltd | Intravaginal drug delivery device |
| JP2002538757A (ja) * | 1997-03-26 | 2002-11-12 | ノボ ノルディスク アクティーゼルスカブ | 食欲制御活性を有するポリペプチド |
| BRPI0414539B8 (pt) * | 2003-09-19 | 2021-05-25 | Novo Nordisk As | composto, composição farmacêutica, e, uso de um composto |
| ITMI20061545A1 (it) * | 2006-08-02 | 2008-02-03 | Mediolanum Pharmaceuticals Ltd | Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo |
-
2009
- 2009-03-17 WO PCT/EP2009/053149 patent/WO2009115525A2/en active Application Filing
- 2009-03-17 JP JP2011500199A patent/JP2011515363A/ja active Pending
- 2009-03-17 CA CA2717459A patent/CA2717459A1/en not_active Abandoned
- 2009-03-17 CN CN2009801096780A patent/CN101977624A/zh active Pending
- 2009-03-17 RU RU2010142903/15A patent/RU2010142903A/ru unknown
- 2009-03-17 EP EP09721933A patent/EP2265280A2/en not_active Withdrawn
- 2009-03-17 BR BRPI0908423-1A patent/BRPI0908423A2/pt not_active IP Right Cessation
- 2009-03-17 AU AU2009226966A patent/AU2009226966A1/en not_active Abandoned
- 2009-03-17 MX MX2010010016A patent/MX2010010016A/es not_active Application Discontinuation
- 2009-03-17 KR KR1020107020784A patent/KR20100135751A/ko not_active Application Discontinuation
- 2009-03-19 CL CL2009000675A patent/CL2009000675A1/es unknown
- 2009-03-19 US US12/407,404 patent/US20100075893A1/en not_active Abandoned
- 2009-03-19 TW TW098108936A patent/TW201000117A/zh unknown
- 2009-03-20 PE PE2009000423A patent/PE20091690A1/es not_active Application Discontinuation
- 2009-03-20 AR ARP090101004A patent/AR071010A1/es unknown
-
2010
- 2010-08-11 IL IL207542A patent/IL207542A0/en unknown
- 2010-08-23 ZA ZA2010/06004A patent/ZA201006004B/en unknown
- 2010-09-28 CO CO10119558A patent/CO6290697A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20091690A1 (es) | 2009-11-13 |
| JP2011515363A (ja) | 2011-05-19 |
| CA2717459A1 (en) | 2009-09-24 |
| WO2009115525A3 (en) | 2010-03-18 |
| EP2265280A2 (en) | 2010-12-29 |
| IL207542A0 (en) | 2010-12-30 |
| CL2009000675A1 (es) | 2009-08-07 |
| TW201000117A (en) | 2010-01-01 |
| BRPI0908423A2 (pt) | 2015-08-04 |
| AU2009226966A1 (en) | 2009-09-24 |
| CO6290697A2 (es) | 2011-06-20 |
| US20100075893A1 (en) | 2010-03-25 |
| ZA201006004B (en) | 2011-05-25 |
| KR20100135751A (ko) | 2010-12-27 |
| RU2010142903A (ru) | 2012-04-27 |
| CN101977624A (zh) | 2011-02-16 |
| AR071010A1 (es) | 2010-05-19 |
| WO2009115525A2 (en) | 2009-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12021550756A1 (en) | Compositions and methods for treating and/or preventing cardiovascular disease | |
| HK1220631A1 (zh) | 用於遞送治療劑的陰離子核心組合物以及製備和使用所述組合物的方法 | |
| MX2010008696A (es) | Composiciones de proteina estabilizadas. | |
| HK1145652A1 (en) | Materials and methods for delivering compositions to selected tissues | |
| MX2012000396A (es) | Metodos y composiciones para uso en tartamientos celulares. | |
| EP2569330A4 (en) | CHLOROTOXINE VARIANTS, CONJUGATES, AND METHODS OF USE THEREOF | |
| MX2013002048A (es) | Conjugados, particulas, composiciones y metodos relacionados. | |
| SG10201408158SA (en) | Composition and methods used during anti-hiv treatment | |
| EP2486052A4 (en) | GENERATION, LABELING AND USE OF ANTI-HER3 ANTIBODIES | |
| EP2464626A4 (en) | PROCESSES, COMPOUNDS AND COMPOSITIONS FOR THE EXPORTS OF 1,3-PROPANE-SULFONIC ACID | |
| EP2262502A4 (en) | COMPOSITIONS AND METHODS FOR RELIEVING DEPRESSION OR ENHANCING COGNITIVE PROCESSES | |
| EP2271301A4 (en) | METHODS AND COMPOSITIONS FOR THE DELIVERY OF AGENTS | |
| EP2361089A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE | |
| IN2012DN00570A (es) | ||
| EP2542255A4 (en) | METHOD AND COMPOSITIONS FOR TREATING THE DEGOS SYNDROME | |
| PL2424374T3 (pl) | Kompozycje środka oczyszczającego i metody jego stosowania | |
| EP2299828A4 (en) | COMPOSITIONS FOR LOW USE AGRICULTURE AND METHODS OF USE | |
| MX342270B (es) | ANTICUERPO NEUTRALIZANTE DE LA INTEGRINA AVß8. | |
| IL218490A (en) | Oxazolopyrimidinones dihydro hydroxybencyalkyloxymethyl are converted, preparations containing them and their use in the preparation of pharmaceutical preparations | |
| ZA200901132B (en) | Human GLP-1 mimetibodies, compositions, methods and uses | |
| EP2269653A4 (en) | COMPOSITION FOR THE STABILIZATION OF BLOCKER AND THE COMPOSITION COMPRISING TRANSDERMAL ABSORBABLE PREPARATION | |
| EP2340297A4 (en) | COMPOSITION, ITS MANUFACTURING METHOD AND USE | |
| EP2342559A4 (en) | METHODS AND COMPOSITIONS FOR PREVENTING ARTIFACTS IN TISSUE SAMPLES | |
| EP2502989A4 (en) | IMPLANT COMPOSITION FOR THE REGENERATION OF NEURAL TISSUE, PREPARATION METHOD AND USES THEREOF | |
| MX2010010016A (es) | Preparacion de composicion farmaceutica para aumentar densidad mineral osea. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |